2025 annual financial data
Spruce Biosciences 2025 Operating margin
Spruce Biosciences 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -36,513,000 USD and net income was -38,966,000 USD.
Operating cash flow was -33,327,000 USD.
Get free Spruce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -36,513,000 USD
- Net income
- -38,966,000 USD
- Operating cash flow
- -33,327,000 USD